1. Home
  2. GKOS vs RDY Comparison

GKOS vs RDY Comparison

Compare GKOS & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$238.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Dr. Reddy's Laboratories Ltd

RDY

Dr. Reddy's Laboratories Ltd

N/A

Current Price

$14.84

Market Cap

9.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
RDY
Founded
1998
1984
Country
United States
India
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
9.9B
IPO Year
2015
2001

Fundamental Metrics

Financial Performance
Metric
GKOS
RDY
Price
$238.12
$14.84
Analyst Decision
Strong Buy
Buy
Analyst Count
13
5
Target Price
★ $243.85
$14.79
AVG Volume (30 Days)
1.5M
★ 2.3M
Earning Date
10-28-2026
10-23-2026
Dividend Yield
N/A
★ 0.43%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $507,442,000.00
N/A
Revenue This Year
$53.82
$4.58
Revenue Next Year
$28.56
$11.95
P/E Ratio
★ N/A
$18.67
Revenue Growth
★ 32.33
N/A
52 Week Low
$93.78
$11.36
52 Week High
$255.19
$15.67

Technical Indicators

Market Signals
Indicator
GKOS
RDY
Relative Strength Index (RSI) 59.90 69.00
Support Level $147.72 $12.91
Resistance Level $255.19 $15.08
Average True Range (ATR) 11.84 0.25
MACD -1.49 -0.03
Stochastic Oscillator 43.31 82.52

Price Performance

Historical Comparison
GKOS
RDY

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: